Graft Rejection
51
6
7
32
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
12 trials with published results (24%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
2.0%
1 terminated out of 51 trials
97.0%
+10.5% vs benchmark
39%
20 trials in Phase 3/4
38%
12 of 32 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 32 completed trials
Clinical Trials (51)
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
Immunologic Risk of Pregnancy in Women With Lung Transplantion : a National Multicentric Study
HLA-Identical Sibling Renal Transplant Tolerance
Molecular HistoMx Assessment for Kidney Transplant Rejection and Management
TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS
ZeroHeart Biopsy - Prediction of Deceased Donor Heart Transplant Performance From Organ Donors Using Pre-Transplant Biopsies - A Pilot Study
Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
Mass Spectrometry-based Proteomics in Microvascular Inflammation Diagnosis in Kidney Transplantation.
MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy
Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure
Pathogenetic Risk Factors for Corneal Graft Rejection
Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation
Correlation Between Pre-transplant ICI Exposure and Post-transplant Graft Rejection
Urine Biomarker for Kidney Transplant Rejection
Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation
A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection
Study of Rituximab to Treat Chronic Renal Transplant Rejection
Monitoring for Tolerance to Kidney or Combined Kidney-Pancreas Transplants